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Immunocytochemical methods were used to compare the GABA system in control mice and two 
mutant strains: spastic which has reduced glycine receptors and retinal degeneration mutan'l in 
which the photoreceptors degenerate and reportedly have increased GABA and GAD levels. We 
found that the spastic mutant retina had reduced GABA-immunoreactivity (IR) in the proximal 
retina, reduced staining for GAD-1440 in the OPL, and reduced GABAA receptor staining in the 
OPL, compared to control. The retinal degeneration mutant retinas had enhanced GABA-IR 
throughout he retina, particularly in Miiller cells, bipolar cells and IPL, and enhancement of 
GABAA receptor staining in the OPL, compared to control. The distributions of GABA-IR, GAD- 
1440-IR and GABAA receptor-IR in retinas of spastic mutant mice that also expressed the re~Fnal 
degeneration phenotype resembled those found in retinas of mice that expressed only the re~!nal 
degeneration phenotype rather than those that expressed only the spastic mutation. No differences 
were observed among the conditions for GAD-65, GAD-67 or GABA-T. Our results with the spastic 
and retinal degeneration mutant mice demonstrate that attenuation in the glycinergic system and 
photoreceptor degeneration, respectively, is accompanied by alterations in different aspects of the 
GABA system, giving impetus for caution in the interpretation of experiments involving genetic 
manipulation of complex phenotypes. © 1997 Elsevier Science Ltd 
Retina GABA Mutant mause Immunocytochemist_rL¢ 
INTRODUCTION 
Since the identification of y-aminobutyric acid (GABA) 
in brain tissue by Roberts and Frankel (1950), GABA has 
been established as the major inhibitory neurotransmitter 
in the central nervous system (Mandel & DeFeudis, 
1979) including the retina (Yazulla, 1986). GABA is a 
transmitter of numerous ubtypes of amacrine cell in all 
species o far investigated and, depending on tile species, 
GABA is used by subtypes of horizontal cell, interplexi- 
form cell, bipolar cell, or ganglion cell (Marc, 1992; 
Yazulla, 1986 for reviews). Among mammals, the mouse 
is used extensively in genetic research and numerous 
mutations affecting the nervous system, including the 
retina, have been identified. However, unlike the retinas 
of primate, cat, rabbit and rat, relatively much less is 
known about the anatomical distribution of neurotrans- 
mitter systems in the mouse retina; some information is 
available regarding GABA, dopamine and glycine 
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neurons in mouse retina (Ballesta et al., 1984; Blanks 
& Roffler-Tarlov, 1982; Brandon, 1985; Kato et al., 
1981; Pinto et al., 1994; Schnitzer & Rusoff, 1984; Wulle 
& Schnitzer, 1989). 
Here, we have focussed on the GABA system of the 
normal, wild-type mouse and two strains of mice that 
have visual deficits that result from separate mutations. 
The first of these mutations, spastic, is recessive and 
results from the aberrant splicing of the #-subunit of the 
glycine receptor, encoded by a gene on mouse chromo- 
some 3 (Mtilhardt et al., 1994). The spastic mutation 
causes reduced levels of glycine receptors in the central 
nervous ystem of homozygotes (Becker, 1990; Becker & 
Hoch, 1991; Pinto et al., 1994; White & Heller, 1982). 
The mutation produces a syndrome similar to human 
hyperekplexia (Becket & Hoch, 1991) and is accom- 
panied by an 80% reduction, but with no change in 
affinity, of [3H]strychnine binding in mouse spinal cord 
(Becker et al., 1986). The visual consequences of the 
spastic mutation are seen in ganglion cells in which 
abnormalities in both spatial and temporal aspects of the 
responses to light are observed (Stone & Pinto, 1992). 
Pinto et al. (1994) observed a significant reduction in the 
glycine-receptor immunolabeling of both the e and # 
subunits of the glycine receptor as well as the 93 kDa 
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cytoplasmic receptor associated protein, gephyrin. As 
upregulation of GABA receptors has been reported in 
other areas of the central nervous ystem (CNS) of the 
spastic mutant mouse (White & Heller, 1982), we 
investigated whether compensatory changes might be 
found in the retinal GABA system. 
The spastic mutation is deleterious to the organism; 
male homozygous mutants rarely breed, though they have 
fertile sperm. Thus, the mutation is maintained using a 
"hybrid inbred" line resulting from a cross between 
C57BL/6J mice, with normal retinas, and C3H/Fe mice, 
every one of which is homozygous for the retinal 
degeneration mutation, found on chromosome 5.As the 
two genes are unlinked, one-fourth of all animals born, 
including the spastic mutants, will have the retinal 
degeneration phenotype. Retinal degeneration mutant 
mice, with degeneration of photoreceptors and their 
synaptic ontacts (i.e. Sonohara & Shiose, 1968; Caley et 
al., 1972; Blanks et al., 1974) have few other changes in 
retinal histology, but have an altered GABAergic system 
in the retina. Grafstein et al. (1972) reported a 20% 
decrease in the number and size of retinal ganglion cells 
of C57BL/6J le rd mutants. Biochemical assays of 
control and rd/rd mice (C3H/HE-N-CRJ strain) have 
revealed striking increases in the GABA content and 
GAD activity in rd/rd mice (Murashima et al., 1990). 
There is probably an interaction between the two 
inhibitory systems in the CNS. Upregulation of GABA 
receptors has been reported in other areas of the CNS of 
the spastic mutant mouse (White & Heller, 1982). We 
studied the retinal GABA system in the hybrid B6C3F3 
mice carrying the spastic mutation and found reductions 
in GABA-immunoreactivity (IR) in the inner retina. This 
leaves open the possibility that functional abnormalities 
of spastic mutant retinas may result, in part, from 
abnormal function of the GABAergic system in addition 
to the expected abnormalities due the reduced function of 
the glycinergic system. We found that the retinal 
degeneration mutation also affects the GABAergic 
system, an effect hat could be due to the loss of photo- 
receptors because the same effects were seen in rd/rd 
mice regardless of the allele at the spastic locus. 
METHODS 
Subjects 
Heterozygous, hybrid breeding pairs of mice (B6C3- 
spa/+; derived from a cross between B6C3F3 spa~spa nd 
B6C3Fe +/+) were obtained from the Jackson Laboratory 
(Bar Harbor, ME, U.S.A.). Pups were tested for the 
spastic phenotype at 3 weeks of age; homozygous spa/ 
spa pups displayed tremor and increased righting time 
(White & Heller, 1982). Control litter-mate mates (___) 
were used as controls. Members of the C3HFe parent 
strain all carry the mutant allele at the retinal degenera- 
tion (rd) locus (LaVail, 1981). Since the rd and spa genes 
are unlinked, one fourth of the animals, including spastic 
mutant animals had the retinal degeneration phenotype. 
Immunochemicals 
The following primary antibodies and antisera were 
used to detect various components of GABAergic 
function. 
GABA antiserum (No. 5), a gift of Dr R. Wenthold, 
was produced in rabbit against GABA conjugated to 
bovine serum albumin with glutaraldehyde (Wenthold et 
al., 1986). Two polyclonal and one monoclonal anti- 
bodies against the GABA biosynthetic enzyme 1- 
glutamate decarboxylase (GAD) were u,;ed: sheep anti- 
rat brain GAD (1440-51) was a provided through the 
laboratory of Clinical Science, NIMH, under the super- 
vision of Dr I. J. Kopin with Drs W Oertel, D. E. 
Schmechel and M. Tappaz (Oertel et al., 1981). 
Monoclonal antibody specific for GAD-65 (Chang & 
Gottlieb, 1988; GAD-6; 1:100) was obtained from the 
Developmental Studies Hybridoma Bank (Department of
Pharmacology and Molecular Sciences, Johns Hopkins 
University School of Medicine, Baltimore, MD, and 
Department of Biology, University of Iowa, Iowa City. 
IA, Contract NO1-HD-6-2915). Rabbit polyclonal anti- 
sera against GAD-67 (K2; Kaufman et al., 1991) was 
obtained from Chemicon International and used at a 
dilution of 1:2000. Rabbit polyclonal antiserum against 
GABA-transaminase (GABA-T), the GABA degradative 
enzyme, a gift of Dr J. Y. Wu was produced against 
mouse brain GABA-T (Lin et al., 1983). Two mono- 
clonal antibodies against the /~2//~3 subunit of the 
GABAAR/BZDR/CI- channel complex were used. 
Monoclonal antibody 62-3G1 (Vitorica et al., 1988), a 
gift of Dr A. L. De Blas was used at a concentration f
1:10. Monoclonal antibody BD-17 (Schoch et al., 1984; 
Richards et al., 1987), a gift of Dr J. G. Richards of 
Hoffmann-La Roche, Ltd, was used at a concentration f 
1:2. We performed experiments in wh!ich retinas were 
double-labeled with anti-GAD-1440 and anti-tyrosine 
hydroxylase (the rate limiting enzyme for dopamine 
synthesis). We used a rabbit polyclonal antisera gainst 
bovine adrenal tyrosine hydroxylase (TH; Eugene 
Technologies) ata concentration f 1:1000. 
Secondary antisera were goat-anti-rabbit conjugated to
FITC, goat-anti-mouse conjugated toFITC (Boehringer- 
Mannheim) and goat anti-rabbit Texas Red (Vector 
Laboratories). 
Histological preparation 
Mice were killed by cervical dislocation. Eyes were 
enucleated; the cornea and lens were removed. Eyecups 
were fixed in 2.5% glutaraldehyde plus 2% paraformal- 
dehyde (for GABA-IR) or in 4% paraformaldehyde (for 
all other primary antisera/antibodies) n 0.1 M phosphate 
buffer (pH 7.4) for 6 hr, rinsed for 1 hr in rinse buffer 
(RB: 0.l M phosphate buffer with 5% sucrose and 
0.15 mM CaCl2) and transferred to 30% sucrose in 
phosphate buffer overnight at 4°C for cryoprotection. The 
eyecups were embedded in a 30%/3% gelatin/egg 
albumin embedding medium and frozen in isopentane 
cooled by liquid nitrogen. 
Cryostat sections (12 #m thick) were washed in 
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FIGURE 1. GABA-IR (1:6000) in the retinas of control (A), spastic 
(B), and rd/rd (C) mice. All conditions are characterized laylabeling of 
numerous cell bodies in the proximal INL, fewer cell bodies in the 
GCL, and stratification i the IPL. Punctate labeling is also visible in 
the OPL of control and spastic retinas. Overall, the pattern of GABA- 
IR in control and spastic retinas is similar, except that he lamination i  
the mid IPL (25% and 55% levels, arrowheads) appears more promi- 
nent in the spastic retina. Major differences are seen with the rd/rd 
retina (C) in which cell bodies of bipolar cells and M611er cells are 
labeled, along with Miiller cell processes that extend fi'om the inner 
limiting membrane to the OPL (arrows). In addition, there are four 
distinct laminae in the IPL. Calibration bar = 5(} #m. 
phosphate-buffered-saline (PBS) for 1 hr and incubated 
in 2% normal goat serum (NGS) in PBS for 15 min. 
Sections were incubated in primary antisera/antibodies 
diluted in PBS with 0.3% Triton X-100 in a humid 
FIGURE 2. GABA-IR (1:1000) in a control mouse retina to illustrate 
punctate processes inthe OPL (arrowheads). Calibration bar = 20 pro. 
FIGURE 3. GAB A-IR (1:12 000) in the retinas of control (A), spastic 
(B), and rd/rd (C) mice. The relative patterns are very similar to those 
shown in Fig. 1, except that he two strata in the IPL of spastic mouse 
are more prominent due to a reduction in GABA-IR in the proximal 
IPL. Also, in the rd/rd mouse, labeling of the MUller cells is reduced 
while the four laminae in the IPL persist. Calibration bar = 50 ~m. 
chamber at 4°C for 60 hr, then washed for 1 hr in PBS, 
incubated in secondary antisera-FITC for 1 hr at 37°C, 
washed in PBS and coverslipped. Sections were viewed 
and photographed on an Olympus BH-2 epifluorescence 
microscope. 
RESULTS 
GABA-immunoreactivity 
Control mouse. GABA-immunoreact iv i ty [Fig. I(A)] 
was found in numerous amacrine cell bodies in the 
proximal 2 layers of the inner nuclear layer (INL) and 
fewer cell bodies in the ganglion cell layer (GCL), likely 
to include ganglion cells as well as displaced amacrine 
cells. With low concentration of antisera (1:6000), 
punctate labeling in the distal INL and outer plexiform 
layer (OPL) was weak, perhaps derived either from 
Mtiller cell processes or from GABA-interplexiform 
cells. At a higher concentration of 1:1000 (Fig. 2), 
punctate GABA- IR  was seen clearly coursing through the 
INL to the OPL, suggestive of GABA interplexiform 
cells. No GABA- IR  was observed in bipolar cells, 
horizontal cells or photoreceptor cells. GABA- IR was 
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FIGURE 4. GAD-IR (GAD-1440) in the retinas of control (A), spastic 
(B), and rd/rd (C) mice. Overall, the patterns are very similar with 
numerous cell bodies in the proximal INL, three major laminae in the 
IPL and a thin layer of processes inthe OPL. Two apparent differences 
are that the intensity of labeling is less in the OPL of spastic retina (B) 
and that fascicles of fibers in the optic fiber layer are labeled heavily in 
the rd/rd retina (C, arrow). Calibration bar = 50/lm. 
distributed throughout the inner plexiform layer (IPL), 
with broad bands of label in the distal 25% and proximal 
40% of the IPL. There also was indication of two thin 
bands of increased GABA-IR at about the 25% and 55% 
levels. 
Spastic mutant mouse. GABA-IR in spastic mutant 
retinas [Fig. I(B)], appeared very similar to that found in 
control retinas except hat the two thin bands of GABA- 
IR at the 25% and 55% levels of the IPL appeared more 
prominent in the spastic mutant. The impression was that 
the broader bands of label in the proximal and distal IPL 
of the spastic retina were reduced in density compared to 
control retinas, thereby enhancing the appearance of the 
narrow strata. The attenuation of the more proximal band 
was more pronounced when the dilution of GABA 
anti sera was increased to 1:12 000 (Fig. 3). There was an 
overall reduction in GABA-IR in both control and spastic 
mutants. Moreover, the spastic mutant retinas showed 
very few intensely GABA-IR cells in the GCL and a loss 
of GABA-IR in the proximal 40% of the IPL, compared 
to control. 
Retinal degeneration mouse. The overall labeling 
pattern of GABA-IR in rd/rd mouse retina [Fig. I(C)] 
was more intense in the INL and IPL compared to control 
and spastic retinas. First, there was extensive labeling of 
the Mtiller cells as evidenced by intense GABA-IR 
extending from the vitreal margin to the retinal pigment 
epithelium. It also appeared as if bipolar cell bodies were 
labeled in the mid INL. Second, there was an additional 
band of GABA-IR at the distal margin of the IPL, two 
distinct bands in the proximal IPL as opposed to the more 
uniform band seen in control, and the two bands at the 
25% and 55% levels appeared broader in 1:he rd/rd retina. 
At a 1:12 000 dilution [Fig. 3(C)], GABA-IR was reduced 
over the Miiller cell processes at the outer and inner 
margins of the retina as well as over cell bodies in the mid 
INL, whereas the labeling over amacrine cells and the 
lamination of IPL seemed less affected. 
GAD-immunoreactivity 
There were differences in distribution among the three 
GAD-antisera but only for GAD-1440 was there one 
apparent difference between control, spastic, and retinal 
degeneration mutant retinas. GAD-14,40-IR (Fig. 4) 
labeled numerous amacrine cell bodies in the proximal 
third of the INL and at least five laminae throughout the 
FIGURE 5. Section of control mouse retina, double labeled for GAD-1440 (A; Texas Red) and tyrosine hydroxylase (TH) (B; 
FITC) immunofluorescence. This figure illustrates that large cell bodies in the INL (arrow) and processes in the OPL 
(arrowheads) colocalize GAD-t440 and TH. Calibration bar = 20 itm. 
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FIGURE 6. GAD-IR (GAD-65) in the retinas of control (A), spastic 
(B), and rd/rd (C) mice. The patterns among the three conditions 
appear identical with numerous cell bodies in the proximal INL, 
scattered cell bodies in the GCL and three major laminae in the IPL, 
with sublamination in the mid IPL. Nonspecific labeling of blood 
vessels i  visible as well (arrowheads). Calibration bar = 50/~m. 
full thickness of the IPL (0-20%, 30-35%, 45-50%, 60- 
70%, 90-100%). In addition, there were thick processes 
in the OPL of control and retinal degeneration mutant 
retinas that were GAD-1440-IR [Fig. 4(A, C)]. These 
processes, viewed at a higher magnification i an oblique 
section (Fig. 5 were double labeled for tyrosine 
hydroxlyase and GAD-1440-IRs and are thus derived 
from processes of dopamine/GABA interplexiform cells. 
GAD-1440-IR in the OPL of spastic retinas [Fig. 4(B)] 
appeared more diffuse than confined to discrete pro- 
cesses, and overall appeared weaker than observed in 
control and retinal degeneration retinas. 
The labeling patterns of anti-GAD-65 (Fig. 6) appeared 
the same for all three phenotypes and had a very similar 
distribution to GAD-antisera 1440 except hat there was 
no staining in the OPL and the density of label at the 90- 
100% level in the proximal IPL appeared less intense 
with anti-GAD-65. 
As with anti-GAD-65, anti-GAD-67 did not label the 
OPL (Fig. 7). Also, the labeling intensity of anti-GAD-67 
was weaker over the amacrine cell bodies. The lamina- 
tion in the IPL consisted of three broad layers and 
appeared more diffuse compared to anti-GAD-1440 and 
anti-GAD-65. A notable difference was that the separa- 
FIGURE 7. GAD-IR (GAD-67) in the retinas of control (A), spastic 
(B), and rd/rd (C) mice. The patterns among the three conditions 
appear identical with numerous cell bodies in the proximal INL and 
three diffuse laminae in the IPL. Calibration bar = 50/~m. 
tion of the three main laminae occurred at the 20% and 
50% levels as opposed to the 25% and 5.';% levels for 
anti-GAD-1440 and anti-GAD-65. The consequence is 
that the two dense GABA-IR bands in the mid-IPL 
overlap regions stained with anti-GAD-67 but not anti- 
GAD-1440 or anti-GAD-65. Also note that the labeling 
intensity in the most proximal IPL (95%) was compar- 
able for anti-GAD-1440 and anti-GAD-67, both of which 
were denser in this region than observed with anti-GAD- 
65. 
GABA-T immunoreactivity 
GABA-T-IR (Fig. 8) had the same distribution in 
control, spastic and retinal degeneration mutant mice. 
GABA-T-IR was punctate in appearance and extended 
from the inner limiting membrane to the outer limiting 
membrane. Punctae appeared arranged in vertical streaks 
in the INL and outer nuclear layer (ONL). There were 
three broad laminae in the IPL with narrow darker bands 
at the 25% and 55% IPL depths. Overall, this pattern of 
GABA-T-IR suggests localization to Mtiller glial cells. 
GABAA receptor f12/f13 subunit immunoreclctivity 
Labeling with mAb 62-3G1 (Fig. 9) in tile inner retina 
of control, spastic and retinal degeneration mutant was 
observed in select cell bodies in the INL and throughout 
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FIGURE 8. GABA-T-IR in the retinas of control (A), spastic (B), and 
rd/rd (C) mice. The patterns among the three conditions appear 
identical with three diffuse laminae in the IPL and punctate labeling 
extending vertically through the full thickness of the retina, a pattern 
indicative of Miiller cell labeling. Calibration bar = 50 #m. 
FIGURE 9. GABA/31//~2 receptor subunit-IR (mAb 62-3G1) in the 
retinas of control (A), spastic (B), and rd/rd (C) mice. The patterns 
among the three conditions appear identical in the IPL with scattered 
cell bodies in the proximal INL and three thin laminae in the IPL. 
Punctate labeling in the OPL is strongest in the rdDd retina, less so in 
control and weakest in the spastic retina. Cell bodies in the mid and 
distal INL, likely to be bipolar cells, are labeled as well. Calibration 
bar = 50/~m. 
the IPL, in which three laminae at the 25%, 55% and 95% 
levels were apparent. Two types of amacrine cell body 
were labeled intensely with mAb 62-3G1 (Fig. 10), one 
type with its soma at the proximal margin of the INL and 
a second type placed more distally in the INL. 
Differences among the three genotypes were noted in 
the outer retina. In control retinas [Figs 9(A) and 10(A)], 
bipolar cell bodies and their processes ascending to the 
OPL were stained weakly but they gave rise to brighter 
punctae in the OPL. Such bright processes in the OPL 
were far less apparent in spastic retinas [Fig. 9(B)]. An 
oblique section through the outer etina of an rd/rd mouse 
clearly shows labeling for mAb 62-3G1 over bipolar cells 
bodies and their processes radiating from the cell body 
into the OPL [Fig. 10(C)]. 
Labeling with BD-17 (Fig. 11) appeared similar to that 
obtained with mAb 62-3G 1, trilaminar labeling in the IPL 
(25%, 55%, 95% levels), two types of labeled amacrine 
cell bodies, and labeled bipolar cell bodies that gave rise 
to stained processes in the OPL. As with mAb 62-3G1, 
bipolar cell processes in the OPL appeared stained more 
intensely in the control and retinal degeneration retinas 
than in spastic retina [Fig. l l(B)]. However, overall, it 
appeared as if the processes in the OPL were stained 
more intensely by BD-17 than mAb 62-3G1. 
rd/rd mice with spastic phenotype 
We found that staining intensity in the OPL of spastic 
mutants was less than in retinal degeneration mutants for 
GAD-1440, mAb 62-3G1, and BD-17. ix, question that 
arose was, would the staining patterns in the OPL of 
mice, in which both mutations were expressed, resemble 
the spastic or retinal degeneration single homozygotes? 
The answer is illustrated for GAD-1440 and BD-17 in 
Fig. 12. Processes in the OPL were stained more 
intensely in rd/rd mice regardless of whether the mice 
with retinal degeneration phenotype also had the spastic 
mutant phenotype. Thus, the consequence of the retinal 
degeneration mutation appears to override the effect of 
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FIGURE 10. GABA//11//2 receptor subunit-IR (mAb 62-3G1) in the 
retinas of control (A) and rdlrd (B) mice. Based on position in the INL, 
two types of amacrine cell are labeled brightly: one at the INL/IPL 
border and the other more distally (arrows). A number of bipolar cell 
bodies with their processes extending to the OPL are labeled clearly 
(arrowheads). The pattern of bipolar cell processes in the OPL of rd/rd 
retina is illustrated in the tangential section (C) in which cell bodies 
and radiating processes are visible (arrowheads). Calibration bar: 
a,b = 20 #m; c = 50 #m. 
FIGURE 11. GABA ]31///2 receptor subunit-IR (mAb BD-17) in the 
retinas of control (A), spastic (B), and rd/rd (C) mice. The patterns 
among the three conditions appear identical in the IPL with scattered 
cell bodies in the proximal INL and three thin lamiaae in the IPL. 
Punctate labeling in the OPL is strongest in the rd/rd retina, less so in 
control and weakest in the spastic retina. Cell bodies in the mid and 
distal INL, likely to be bipolar cells, are labeled as well. Calibration 
bar = 50 #m. 
the spastic mutation in regard to effects on the GABA 
system. 
DISCUSSION 
Our findings on the GABA system in the retina of  the 
control mouse are similar to those reported using a 
variety of GABA markers in the retinas of  other rodents, 
including mouse, rat, guinea pig, and ground squirrel 
(Agardh et al., 1987; Brandon, 1985; Caruso et al., 1989; 
Greferath et al., 1993; Mosinger et al., 1986; Osborne et 
al., 1986; Schnitzer & Rusoff. 1984; Vaughn et al., 
1975). Namely,  GABA releasing neurons are l ikely to be 
restricted to several subtypes of amacrine cell in both the 
INL and GCL  and a subtype of  interplexiform cell with 
processes in the OPL. We found no evidence to indicate 
that photoreceptors, horizontal cells or bipolar cells 
synthesize, contain or degrade GABA.  A summary 
schematic of  the distributions of  the various GABA 
markers in the IPL of the three condit ions is shown in Fig. 
13. 
Control  mouse 
GABA- IR  in the gangl ion cell layer. GABA- IR  in cells 
of  the GCL has been observed in the retinas of all 
mammals  so far investigated (i.e. Agardh et al., 1987; 
Koontz et al., 1993; Mosinger et al., 198(5; W/issle & 
Chun, 1989). Most of these cells are displaced amacrine 
cells that include chol inergic (Brecha et al., 1988; 
Kosaka et al., 1988; Vaney & Young, 19881, and, at least 
in rat and mouse, a very small percentage of  dopaminer-  
gic amacrine cells (Ballesta et al., 1984; Simon et al., 
1989; Wul le & Schnitzer, 1989). A small percentage of 
these GABA- IR  GCL cells in rabbit, ground squirrel, and 
rat retina are ganglion cells (Lugo-Garcfa & Blanco, 
1991; Caruso etal . ,  1989; Yu etal . ,  1988). Thus, some of 
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FIGURE 12. l_,ocalization fGAD-1440 (A) and BD-17 (B) in retinas 
of mice expressing both retinal degeneration and spastic phenotypes. 
Note that he labeling in the OPL is denser than seen with just the 
spastic mutation [Figs 4(B) and 11(B)I and more comparable to that 
observed with the rd/rd mutation [Figs 4(C) and 11(C)]. Calibration 
bar = 50/tin. 
the labeled neurons we observed in the GCL of mouse are 
probably ganglion cells. 
GAD-65 and GAD-67.  The immunocytochemical 
localization of both molecular forms of GAD, GAD-65, 
and GAD-67, appear quite similar in that both are 
restricted to amacrine cells in the INL and are broadly 
distributed in three laminae in the IPL. However, three 
differences are noted. First, GAD-65 has a more 
discretely laminar appearance in the IPL whereas 
GAD-67 appears more diffuse; second, GAD-67 stains 
more dense in the most proximal IPL; third, the two 
proximal bands of GAD-67 are displaced istally about 
5% such that the dark borders between the lamina occur 
at 20% and 50% depths rather than 25% and 55% depths. 
A differential distribution of GAD-65 and GAD-67 has 
been noted in cat and monkey retina in which both GAD 
forms are present in overlapping populations of amacrine 
cells but only one form (GAD-65 in monkey; GAD-67 in 
cat) is present in horizontal cells (Vardi et al., 1994). 
Also, in cat, GAD-67 appears localized to larger 
amacrine cells that colocalize other transmitters, whereas 
GAD-65 appears localized to smaller amacrine cells that 
may not contain another transmitter (Vardi & Auerbach, 
1995). Recently, Brandon and Criswell (11995) showed 
that the GABA-containing starburst amacrine cells in 
rabbit retina contain GAD-67 not GAD-65. This is likely 
to be the case for mouse as well because the comparative 
lamination in the IPL (Fig. 13) shows that GAD-65 does 
not overlap the GABA-IR bands in the mid-IPL (25%, 
55% levels), whereas GAD-67 does. Thus, the distal 
extension of the GAD-67 bands is just enough to overlap 
the processes of the presumptive starburst amacrine cells. 
It is clear from the different laminar patterns in the IPL, 
particularly in the most proximal layer, that GAD-65 and 
GAD-67 are expressed in different hough overlapping 
populations of amacrine cells. 
GAD-1440.  The distribution of GAD 1440 in the IPL 
appears as a combination of that produced by GAD-65 
and GAD-67: the discrete lamination of GAD-65 with the 
increased staining in the proximal IPL as with GAD-67. 
This combined pattern is to be expected because the 
polyclonal GAD-1440 (Oertel et al., 1981) has broad 
recognition of both molecular forms of GAD, although 
there is a preference for GAD-65 (Kaufman et at., 1991). 
Note that GAD-1440 also does not overlap the GABA-IR 
bands at the 25% and 55% IPL depths (Fig. 13). It 
therefore was very surprising the GAD-1440 labeled 
processes in the OPL that were not labeled with either 
CONTROL SPASTIC rd/rd 
°ll lJtll lii tll 
~ 50 ii 
FIGURE 13. Schematic illustration of the labeling patterns obtained with the various GABA markers in the IPL of Conrail, spastic and rd/nt 
mice. Lamination i the IPL is indicated from the INL border (0%) to the GCL border (100%). Antisera include: GABA, GABA-T, GAD-1440, 
GAD-65, GAD-67, and GABAA receptor antibodies: mAb 62-3G1 and BD-17. A major point is that he increased bands of GABA-IR label at the 
25% and 55% levels overlap labeling of GABA-T, GAD-67, mAb 62-3G1 and BDI7 but not labeling of GAD-1440 or GAD-65. The relative 
labeling intensity has been subjectively i lustrated as: weak (stippled), moderate (gray), and intense (black). The horizontal dotted lines through 
the figure are at the levels of the stratification f starburst amacrine cells in sublaminae (A) and (B). 
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GAD-65 or GAD-67. This labeling is probably valid 
because the same processes are labeled for tyrosine- 
hydroxylase; all dopaminergic neurons in mouse retina 
also label for GABA-IR, (Wulle & Wagner, 1990), and 
dopamine neurons in mouse retina include interplexiform 
cells with processes in the OPL (Ballesta et al., 1984; 
Wulle & Schnitzer, 1989). It seems evident hat there is 
an epitope of GAD in mouse IPC processes that is 
recognized by polyclonal GAD-1440 but not by the more 
specific GAD-65 or GAD-67 antibodies. The implication 
is that the combined use of GAD-65 and GAD-67 
antibodies does not provide a complete picture of GAD 
containing neurons in the retina. 
GABAA receptor f12/f13 subunits. The distribution of 
two antibodies against he/~2/]33 subunits of the GABAA 
receptor (mAb 62-3G1 and BD-17) appeared identical in 
the IPL, but different in the OPL in which BD--17 labeled 
bipolar cell bodies and dendrites more intensely than 
mAb 62-3G1. Although both antibodies have been 
reported to recognize the same epitopes of the /~2//~3 
subunits (Ewert et al., 1992), the labeling patterns in the 
retina of all species o far investigated are not the same in 
the outer retina. For example, the OPL of fish retina is 
labeled only by mAb 62-3G1 (Lin & Yazulla, 1994; 
Yazulla et al., 1989). However, the OPL of monkey and 
cat is not labeled by mAb 62-3G1 (Hughes et. al., 1989, 
1991) but the OPL is labeled by BD-17 not only in cat 
and monkey (Vardi et al., 1992; Vardi & Sterling, 1994) 
but also in rat, rabbit and human (Greferath et al., 1994, 
1995; Vardi & Sterling, 1994). The mouse then is 
consistent with other mammalian retinas in which the 
OPL, in this case bipolar cell dendrites, is labeled more 
intensely with BD-17. 
Our data showing the presence of GABAA receptor/~2/ 
/~3 subunits on bipolar cell dendrites supports the 
electrophysiological data of Suzuki et al. (11990) who 
showed that GABA induced currents in isolated mouse 
bipolar cells when GABA was applied to the: dendrites, 
although the induced current was about 50% less than 
when GABA was applied to the axon terminal. Diffusion 
of GABA from the OPL to the IPL could not account for 
the OPL-induced responses because GABA had a 
negligible effect when applied to the axon in the IPL 
even though this position was closer to the axon terminal. 
Thus, GABAA receptors are present on mouse bipolar 
cell dendrites and the likely source of endogenous GAB A 
is the GABA/dopamine interplexiform cell. One curiosity 
is that GABA-IR in the OPL is sparse and punctate 
compared to the well-defined processes stained by TH-IR 
and GAD-1440-IR. We have no explanation for this 
difference and presume that for some reason, GABA-IR 
does not indicate the full extent of the GABAergic 
processes in the OPL. 
The glial localization of GABA-T in the mouse is 
consistent with rat retina and accounts for observations 
that GABA-IR is not found in Miiller cells unless GABA- 
T activity is inhibited (Cubells et al., 1988; Neal et al., 
1989). 
Differences among genotypes 
Four differences were noted among control, spastic 
and retinal degeneration mice. First, GABA-IR was 
reduced in the IPL and GCL of spastic mutant retina. 
Second, GABA-IR was enhanced in the retinal degen- 
eration mutant retina. Third, GAD-1440 was reduced 
over processes in the OPL of spastic mutant retina. 
Fourth, GABAA receptor IR was reduced over bipolar 
cell dendrites in spastic mutant retinas. The reduction of 
GAD-1440 and GABAA receptor IR in the OPL of 
spastic mutants did not occur in mice that also carried the 
retinal degeneration mutation. 
Control vs spastic mouse 
GABA-IR. The appearance of GABA-IR in control and 
spastic mutant retinas appeared very similar at dilutions 
of GABA antisera from 1:1000 to 1:6000. However at 
higher dilutions, in spastic retinas, there was a relative 
reduction in the number of GABA-IR cells in the GCL 
and the prominent appearance of a narrow strata in the 
proximal IPL. Two narrow strata, one each just distal and 
proximal to the mid region of the IPL, resembled what 
one would expect for starburst amacrine cells, choliner- 
gic amacrine cells that have been shown to colocalize 
GABA in the retinas of rabbit and rat (Brecha et al., 1988; 
Kosaka et al., 1988; Vaney & Young, 1988). In this 
regard it is expected that mouse retina would contain 
starburst amacrine cells that also contained GABA. Of 
greater interest is the reason for the decrease in GABA-IR 
in the proximal retina of spastic mice that made the 
bilamination in the IPL so prominent compared to 
control. It appears that the relative reduction in GABA- 
IR of spastic retinas was restricted to the most proximal 
IPL and cells in the GCL. However, there was no 
apparent change in the distribution of GAD, GABA-T or 
GABAA receptors in the proximal IPL of spastic retinas. 
Thus, the reduction in GABA-IR levels should not be due 
to the loss of GABA synthesizing or receptive neurons. 
One alternative is that GABA-containing anglion cells 
lost their ability to take up and subsequently store GABA. 
Both [3H]GABA uptake and expression o:f the GAT-1 
GABA transporter have been localized to numerous cells 
in the mouse and rat GCL, and at least in rat ~,;ome of these 
have been shown to include ganglion cells (Blanks & 
Roffler-Tarlov, 1982; Brecha & Weigmann, 1994; Ruiz 
et al., 1994). Also, whole cell recordings from dissociated 
ganglion cells in immature mice (postnw~al day 1-6) 
showed that some ganglion cells responded with an 
increased frequency of spontaneous synaptiLc urrents to 
applied GABA, indicative of some depolari~'ing action of 
GABA (Bahring et al., 1994). High affinity GABA 
uptake is electrogenic (Malchow & Ripps, 1990) and it is 
possible that GABA uptake by a population of ganglion 
cells could modulate sensitivity of these cells. If so, then 
the spastic mouse may have a defect in GABA uptake in 
ganglion cells and this could affect the sensitivity or 
responsivity to light. 
GABAA receptor ~2/~3 subunits. Both mAb 62-3G1 
and BD-17 showed reduced labeling over' bipolar cell 
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processes in the OPL of spastic mutants that did not have 
the retinal degeneration phenotype compared to control 
and rd/rd retinas. One possibility was a down regulation 
of GABA receptors in response to increased GABA 
release by interplexiform processes in the OPL. Although 
there was an overall reduction in GABA-IR levels in the 
inner retina of spastic mice, we found no indication of an 
increase or decrease in GABA-IR labeling in the OPL of 
spastic mutant mice and only a small decrease in GAD- 
1440 in the spastic OPL. Curiously, the amount of 
GABA-IR in the OPL was not comparable to what would 
be expected given the level of GAD-1440 and GABA- 
receptor IRs. 
Spastic mutant mice have retinal ganglion cells with 
abnormal receptive field organization: in mutant retinas, 
an annular stimulus does not elicit a response that is 
characteristic of the surround mechanism; whereas in 
control mice, an annular stimulus always evokes a 
surround response from cells with concentric center- 
surround organization. However, illumination of the 
receptive field periphery attenuates the center-type 
responses evoked from both spastic mutant and control 
retinas (Stone & Pinto, 1992). The finding that glycine 
receptor density was reduced in the IPL, but not the OPL, 
suggested that the surround responses were mediated by 
glycinergic synapses in the IPL and surround antagonism 
was mediated by glycinergic synapses in the OPL (Pinto 
et al., 1994). However, the present results suggest an 
alternative or complementary possibility: the inability to 
evoke surround-type r sponses may result from a deficit 
of GABA neurotransmitter in the IPL or GABAA 
receptors in the OPL. 
Control vs retinal degeneration mutant mouse 
Aside from the loss of photoreceptors and their 
synaptic contacts in the OPL (i.e. Sonohara & Shiose, 
1968; Caley et al., 1972; Blanks et al., 1974) little other 
changes in retinal histology have been noted in rdlrd 
mice (Grafstein et al., 1972). However, biochemical 
studies have shown alterations in dopamine metabolism 
(Nir & Iuvone, 1994) of rds mice; although no changes in 
dopamine neurons were detected using histofluorescence 
techniques in the dystrophic C3H mouse (Kato et al., 
1981). Duvoisin et al. (1995) reported changes in the 
expression of glutamate receptor subunits in rdlrd mouse: 
KA-1 was reduced, GluR7 was increased and seven other 
subunits were unchanged. There also appear to be 
significant differences in the GABA system of rdlrd 
mice (Murashima et al., 1990). 
GABA-IR. As determined by GABA-IR, we found a 
large increase in the GABA content of rd/rd retinas. This 
increase could be accounted for largely by Mtiller cells 
that were labeled heavily from their end feet to the OPL. 
Numerous cell bodies in the mid INL were labeled with 
GABA-IR as well which seemed to include bipolar cells. 
The dense band of GABA-IR that appeared at the distal 
border of the IPL in rdlrd retinas could to be due to 
MiJller cell processes because a similar band is labeled by 
GABA-T, an enzyme restricted mostly to Mialler cells 
(see Fig. 9). However, at a 1:12000 dilution of GABA 
antisera, the Mtiller cell labeling was reduced markedly, 
while the thin band of GABA-IR in the distal IPL is still 
quite visible. Ordinarily GABA-IR is virtually undetect- 
able in MUller cells of control mouse retina or in rat retina 
unless GABA-T activity is inhibited (Cubells et al., 1988; 
Neal et al., 1989). Alternatively, this distal band as well 
as the broader labeling at the 25% and 55% levels could 
be due to processes of cone bipolar cell types. Recently, 
in rat retina, Euler and W~ssle (1995) described cone 
bipolar cells with cell bodies in the mid INL and 
monostratified at the most distal and mid IPL levels, 
similar to the additional GABA-IR labeling seen in the 
rd/rd mouse. It is likely that both Mtiller cells and bipolar 
cells contribute to the additional GABA-IR in the rd/rd 
mouse retina. 
Biochemical assays of control (C57BL) and dystrophic 
(C3H) mice showed a significant increase in retinal 
GABA content (twofold) and GAD activity (fourfold) in 
the rdlrd mouse (Murashima et al., 199011. However, no 
differences in glutamate l vels and only sraall intraretinal 
differences in GABA-T activity were noted. Our data 
support he biochemical data regarding GABA content 
and localize the increase to MUller and bipolar cells. 
However, we noted no obvious difference in GAD-IR 
staining. Isolated mouse Miiller cells take up [3H]GABA 
(Sarthy, 1982), and in the absence of any apparent change 
in GABA-T levels, the M[iller cells appear to accumulate 
excess GABA released presumably from amacrine cells. 
The role of the increased GABA is unclear. Murashima et 
al. (1990) reported that, unlike control waice, light- and 
dark-adapted retinas of dystrophic C3H mice had the 
same levels of GABA and GAD, and they suggested that 
the excess GABA was formed in response to photo- 
receptor degeneration. This suggestion was based on the 
hypothesis that GABA serves as a trophic factor in retinal 
development as well as a neurotransmitter (Madtes & 
Redburn, 1983; Wolfe, 1981). 
GABAA receptor ~2/~3 subunits. Bipolar cell dendrites 
of rdlrd mice also showed increased levels of staining for 
the/~2//~3 subunits of the GABAA receptor, particularly 
for antibody mAb 62-3G1. The increased staining of rd! 
rd retinas was less marked for BD-17, which stained the 
OPL more than mAb 62-3G1, even in control retinas. 
This increased staining of bipolar cells was unique to the 
retinal degeneration mutation condition regardless of 
whether the mice displayed the spastic phenotype. As yet 
we are unaware of any anatomical studies regarding the 
development of GABA receptors in mammalian retina. It 
is possible that the increase in GABAA receptor staining 
is related to the increased GABA levels as part of a 
general response to photoreceptor degeneration. 
Concluding remarks 
The use of mutant animals to study complex 
physiological processes has been productive in testing 
hypotheses generated by other types of experiments and 
to identify novel genes involved in these processes (see 
Takahashi et al., 1994 for review). It is tempting to 
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assume that when a genet ic les ion is made which  affects a 
specif ic gene product,  the phys io log ica l  consequences  
result  f rom an alterat ion in the altered gene product.  
However ,  many  results f rom gene knockout  exper iments  
show that l ittle or no alterat ion in phenotype results f rom 
the ablat ion o f  a gene thought  o be invo lved  in a process. 
Our  results with the spastic mutant mouse  demonstrate  
that attenuation in the g lyc inerg ic  system is accompan ied  
by a decrease in the GABA system, g iv ing added reason 
for caut ion in the interpretat ion of  exper iments  invo lv ing  
genet ic manipulat ion of  complex  phenotypes.  This  is 
i l lustrated further by our observat ions that the reduced 
label ing of  GAD-1440,  mAb 62-3G1,  and BD-17  in the 
OPL  of  spastic mutants only occurs i f  the spastic mutants 
do not also express the retinal degeneration mutat ion.  
We infer f rom this that the consequence  o f  ret inal  
degenerat ion on GABA funct ion in the OPL  offsets 
whatever  compensatory  ef fect  the spastic mutat ion has 
on the GABA system. 
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